Evaluation of polycystic ovary syndrome pharmacotherapy

Ceska Slov Farm. 2024;73(E3):1-6. doi: 10.36290/csf.2024.031.ABSTRACTPolycystic ovary syndrome (PCOS) is a complex endocrine disorder that affects approximately 5-10 % of women of reproductive age. PCOS can have a significant impact on the quality of life of affected women, contributing to fertility

M Mária Kolesárová

Navigating the Computational Landscape for Drug Repurposing

Annu Rev Pharmacol Toxicol. 2026 Jan;66(1):149-170. doi: 10.1146/annurev-pharmtox-121924-042636.ABSTRACTGiving old drugs new uses, a process known as drug repurposing, is an attractive strategy for finding therapeutic candidates for a wide number of diseases. In this context, data-driven approaches

A Andrea Álvarez-Pérez

Microplastics and Atherosclerosis: Mechanisms

Annu Rev Pharmacol Toxicol. 2026 Jan;66(1):369-390. doi: 10.1146/annurev-pharmtox-062124-113011.ABSTRACTMicroplastics are emerging as mediators in the interaction between environmental pollutants and cardiovascular health. Micro- and nanoplastics (MNPs) can enter the human body through ingestion, in

R Raffaele Marfella

The many faces of cholesterol in autosomal dominant polycystic kidney disease

Kidney Int. 2026 Feb;109(2):269-272. doi: 10.1016/j.kint.2025.11.007.ABSTRACTAutosomal dominant polycystic kidney disease has some effects on cholesterol metabolism and cardiovascular disease that are shared with other chronic kidney diseases and others that are distinctive and directly caused by di

V Vicente E Torres

Socioeconomic disparities in adult mortality in Latin America

BMJ Glob Health. 2026 Jan 23;11(1):e018400. doi: 10.1136/bmjgh-2024-018400.ABSTRACTINTRODUCTION: Large socioeconomic disparities in healthcare utilisation and health outcomes have been well-documented in Latin American countries. However, little is known about disparities in mortality rates. We esti

G Giancarlo Buitrago